-
公开(公告)号:US20120108595A1
公开(公告)日:2012-05-03
申请号:US13382469
申请日:2010-06-28
申请人: Anthony Ogawa , Feroze Ujjainwalla , Lin Chu , Bing Li , Lan Wei , Jinyou Xu , Hyun Ok , Aaron Lackner , Ihor Kopka
发明人: Anthony Ogawa , Feroze Ujjainwalla , Lin Chu , Bing Li , Lan Wei , Jinyou Xu , Hyun Ok , Aaron Lackner , Ihor Kopka
IPC分类号: A61K31/4196 , C07D471/04 , C07D249/08 , C07D401/12 , C07D403/12 , C07D405/12 , C07D487/04 , C07F5/04 , A61K31/4245 , A61K31/437 , A61K31/4439 , A61K31/506 , A61K31/422 , A61K31/519 , A61K31/497 , A61P9/10 , A61P29/00 , A61P19/02 , A61P11/06 , A61P1/04 , A61P1/00 , A61P17/06 , C07D413/12
CPC分类号: G01C23/00 , G08G5/0056
摘要: Cyclohexyl sulfonamide compounds which are platelet-activating factor (PAF) receptor antagonists. Said compounds may be useful, for example, for the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders.
摘要翻译: 作为血小板活化因子(PAF)受体拮抗剂的环己基磺酰胺化合物。 所述化合物可用于例如治疗动脉粥样硬化或其它PAF介导的病症,包括炎性,心血管和免疫疾病。
-
公开(公告)号:US09029377B2
公开(公告)日:2015-05-12
申请号:US13382469
申请日:2010-06-28
申请人: Anthony Ogawa , Feroze Ujjainwalla , Lin Chu , Bing Li , Lan Wei , Jinyou Xu , Hyun Ok , Aaron Lackner , Ihor Kopka
发明人: Anthony Ogawa , Feroze Ujjainwalla , Lin Chu , Bing Li , Lan Wei , Jinyou Xu , Hyun Ok , Aaron Lackner , Ihor Kopka
IPC分类号: A61K31/50 , A61K31/4965 , A61K31/505 , A61K31/44 , A61K31/4245 , A61K31/4196 , A61K31/42 , C07D487/00 , C07D401/00 , C07D403/00 , C07D231/02 , C07D271/00 , C07D261/02 , C07D249/08 , G01C23/00 , G08G5/00
CPC分类号: G01C23/00 , G08G5/0056
摘要: Cyclohexyl sulfonamide compounds which are platelet-activating factor (PAF) receptor antagonists. Said compounds may be useful, for example, for the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders.
摘要翻译: 作为血小板活化因子(PAF)受体拮抗剂的环己基磺酰胺化合物。 所述化合物可用于例如治疗动脉粥样硬化或其它PAF介导的病症,包括炎性,心血管和免疫疾病。
-